Diseases [C] » Musculoskeletal Diseases [C05] » Bone Diseases » Spinal Diseases » Spondylitis » Spondylarthritis » Spondylarthropathies
Diseases [C] » Musculoskeletal Diseases [C05] » Joint Diseases » Arthritis » Spondylarthritis » Spondylarthropathies
Description
Heterogeneous group of arthritic diseases sharing clinical and radiologic features. They are associated with the HLA-B27 ANTIGEN and some with a triggering infection. Most involve the axial joints in the SPINE, particularly the SACROILIAC JOINT, but can also involve asymmetric peripheral joints. Subsets include ANKYLOSING SPONDYLITIS; REACTIVE ARTHRITIS; PSORIATIC ARTHRITIS; and others. MeSH
Hierarchy View
Subtype Terms (3)
Arthritis, Psoriatic
82 drugs (56 approved, 26 experimental)
Arthritis, Reactive
13 drugs (8 approved, 5 experimental)
Axial Spondyloarthritis
38 drugs (28 approved, 10 experimental)
Approved Indicated Drugs (2)
Phase 3 Indicated Drugs (1)
Phase 2 Indicated Drugs (1)
Organization Involved with Phase 4 Indications (15)
Organization Involved with Phase 3 Indications (8)
Organization Involved with Phase 2 Indications (1)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
